 |
PharmacovigilancePharmacovigilance continuously monitors drug safety and takes measures to protect public health. ANFARM has a comprehensive Pharmacovigilance System in place, in compliance to the EU pharmacovigilance directives (Regulation (EC) No 726/2004, Directive 2001/83/EC, Volume 9A).
|
ANFARM is a registered user of EUDRAVIGILANCE (EVWEB) and MedDRA.
Adverse Drug Reaction reporting is very important and ensures the continuous monitoring and the benefit/risk evaluation of medicinal products.
Suspected Adverse Drug Reactions are collected by the Pharmacovigilance department and are reported to Competent Authorities.
To report an adverse event
ANFARM invites Health Care Professionals and consumers (patients, patient caregivers) to report possible side effects via phone on +30 210 6831632 or via email at: phvigilance@anfarm.com
Alternatively, the Side Effects can be reported through the national reporting system to the National Competent Authorities. For Greece, to the National Medicines Agency (EOF), Tel: +30 213 2040380/337, Fax: +30 210 6549585, http://www.eof.gr.
